Tributary Capital Management LLC grew its holdings in shares of Viavi Solutions Inc. (NASDAQ:VIAV – Free Report) by 92.9% in the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 2,207,642 shares of the communications equipment provider’s stock after acquiring an additional 1,063,330 shares during the quarter. Tributary Capital Management LLC owned 0.99% of Viavi Solutions worth $28,015,000 at the end of the most recent quarter.
A number of other hedge funds and other institutional investors have also bought and sold shares of the company. SG Americas Securities LLC lifted its stake in shares of Viavi Solutions by 28.6% in the third quarter. SG Americas Securities LLC now owns 70,737 shares of the communications equipment provider’s stock worth $898,000 after acquiring an additional 15,740 shares during the period. Moran Wealth Management LLC bought a new position in shares of Viavi Solutions during the 3rd quarter worth approximately $753,000. Robeco Institutional Asset Management B.V. purchased a new stake in Viavi Solutions during the third quarter worth about $1,442,000. Financiere des Professionnels Fonds d investissement inc. grew its stake in shares of Viavi Solutions by 30.1% during the 3rd quarter. Financiere des Professionnels Fonds d investissement inc. now owns 20,217 shares of the communications equipment provider’s stock worth $257,000 after acquiring an additional 4,678 shares during the period. Finally, VIRGINIA RETIREMENT SYSTEMS ET Al bought a new position in shares of Viavi Solutions in the third quarter worth $226,000. Institutional investors own 95.54% of the company’s stock.
Wall Street Analysts Forecast Growth
Several analysts have recently weighed in on VIAV shares. Argus raised their price objective on shares of Viavi Solutions from $16.00 to $23.00 and gave the company a “buy” rating in a research report on Wednesday, November 5th. Rosenblatt Securities lifted their price target on shares of Viavi Solutions from $15.00 to $19.00 and gave the company a “buy” rating in a report on Thursday, October 30th. Stifel Nicolaus raised their target price on Viavi Solutions from $18.00 to $20.00 and gave the company a “buy” rating in a research note on Wednesday, December 17th. UBS Group upped their price target on Viavi Solutions from $12.00 to $17.00 and gave the stock a “neutral” rating in a research note on Thursday, October 30th. Finally, Needham & Company LLC increased their price objective on Viavi Solutions from $16.00 to $20.00 and gave the stock a “buy” rating in a report on Thursday, October 30th. Seven equities research analysts have rated the stock with a Buy rating, two have assigned a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat.com, Viavi Solutions has an average rating of “Moderate Buy” and a consensus price target of $17.44.
Insider Activity
In related news, Director Keith Barnes sold 121,467 shares of the firm’s stock in a transaction that occurred on Monday, November 10th. The shares were sold at an average price of $18.18, for a total value of $2,208,270.06. Following the sale, the director owned 27,213 shares in the company, valued at approximately $494,732.34. This trade represents a 81.70% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, CEO Oleg Khaykin sold 85,836 shares of the firm’s stock in a transaction dated Monday, December 1st. The stock was sold at an average price of $17.63, for a total value of $1,513,288.68. Following the completion of the transaction, the chief executive officer directly owned 2,025,005 shares in the company, valued at $35,700,838.15. The trade was a 4.07% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders sold 606,226 shares of company stock valued at $10,714,820 over the last three months. Corporate insiders own 1.80% of the company’s stock.
Viavi Solutions Price Performance
VIAV opened at $18.54 on Thursday. The firm has a market cap of $4.14 billion, a PE ratio of 264.86 and a beta of 0.94. The stock has a 50-day moving average price of $17.72 and a 200-day moving average price of $13.61. Viavi Solutions Inc. has a 1 year low of $8.10 and a 1 year high of $19.75. The company has a debt-to-equity ratio of 0.88, a current ratio of 1.99 and a quick ratio of 1.74.
Viavi Solutions (NASDAQ:VIAV – Get Free Report) last issued its earnings results on Wednesday, October 29th. The communications equipment provider reported $0.15 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.13 by $0.02. The firm had revenue of $299.10 million for the quarter, compared to the consensus estimate of $294.35 million. Viavi Solutions had a net margin of 1.33% and a return on equity of 10.70%. The business’s revenue was up 25.6% on a year-over-year basis. During the same quarter in the prior year, the firm posted $0.06 earnings per share. Viavi Solutions has set its Q2 2026 guidance at 0.180-0.200 EPS. Sell-side analysts predict that Viavi Solutions Inc. will post 0.26 earnings per share for the current fiscal year.
Viavi Solutions Profile
Viavi Solutions Inc is a provider of network test, monitoring and assurance solutions for communications service providers, cable operators, enterprises and government agencies. The company offers an extensive portfolio of fiber optic and copper cable test and measurement instruments, wireless network testing equipment and network performance monitoring software. Its products are designed to support the deployment, maintenance and optimization of high-speed broadband, 5G wireless, data center and enterprise networks.
Viavi’s product offerings are organized into two primary segments: Network & Service Enablement and Optical Security & Performance.
Featured Stories
- Five stocks we like better than Viavi Solutions
- You Still Think Silver’s a Joke? Watch What Happens Next.
- This week’s 20x (missed it?)
- A U.S. “birthright” claim worth trillions – activated quietly
- A month before the crash
- YDES Could Be 2026’s Biotech Breakthrough
Receive News & Ratings for Viavi Solutions Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Viavi Solutions and related companies with MarketBeat.com's FREE daily email newsletter.
